Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CannaSorb
- Development stage
- Unknown
- Lead developer
- Synergy Life Sciences
- Modality
- Small Molecules
- Administration
- Oral, Topical
01
Overview
CannaSorb is a water-soluble cannabinoid ingredient developed by Synergy Life Sciences for use in consumer products such as beverages, edibles, and topicals. The flagship version, CannaSorb CB-Active, is derived from GRAS-certified CBD isolate and utilizes a patented chemical conversion process—similar to polysorbate chemistry—to transform fat-soluble cannabinoids into truly water-soluble compounds. This technology enables clear dilution in aqueous solutions and enhances bioavailability and physiological activity compared to standard CBD isolates. It is available as a 100% active liquid or a 50% active flowable powder, and is manufactured in an FDA-audited facility.
- Brand names
- CannaSorbCannaSorb CB-ActiveCannaSorb Hemp Infusion Concentrate
- Other names
- CannaSorb HIC
02
Targets
Beyond the preview
Go deeper on CannaSorb.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CannaSorb.